SCHEMBL20174554

SCHEMBL20174554

c1ccc2c(c1)-c1ccccc1C21c2cccc(-c3ccc4ccc5cccnc5c4n3)c2-c2sc3ccccc3c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
OPRK1 P41145 2/20 0.35
KMT2A Q03164 2/20 0.35
ESR1 P03372 1/20 0.35
POLB P06746 1/20 0.35
AGTR1 P30556 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
CCR1 P32246 3/20 0.34
CCR8 P51685 3/20 0.34
CCR5 P51681 2/20 0.34
ALOX15 P16050 2/20 0.34
TSHR P16473 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TDP1 Q9NUW8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174733 0.93 LMNA (0.37) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL20174682 0.85 LMNA (0.35) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL20174547 0.85 LMNA (0.34) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL20174557 0.84 AR (0.40) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL20174510 0.81 KDM4E (0.41) LMNAKDM4EMAPTALDH1A1POLB
SCHEMBL20174527 0.79 PDK2 (0.39) KDM4EMAPTALDH1A1TSHRSMN1; SMN2
SCHEMBL20174522 0.79 MAPT (0.37) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL20174563 0.79 KDM4E (0.35) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL18590030 0.78 KDM4E (0.33) LMNAKDM4EMAPTALDH1A1MEN1
SCHEMBL25766691 0.78 KDM4E (0.39) LMNAKDM4EMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG LMNA 3057/4885KDM4E 3633/4885MAPT 811/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG LMNA 3057/4885KDM4E 3633/4885MAPT 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.